NL262354A - - Google Patents

Info

Publication number
NL262354A
NL262354A NL262354DA NL262354A NL 262354 A NL262354 A NL 262354A NL 262354D A NL262354D A NL 262354DA NL 262354 A NL262354 A NL 262354A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL262354A publication Critical patent/NL262354A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
NL262354D 1960-03-17 NL262354A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15549A US3039929A (en) 1960-03-17 1960-03-17 Stable isoproteronol compositions

Publications (1)

Publication Number Publication Date
NL262354A true NL262354A (fr)

Family

ID=21772038

Family Applications (1)

Application Number Title Priority Date Filing Date
NL262354D NL262354A (fr) 1960-03-17

Country Status (6)

Country Link
US (1) US3039929A (fr)
BE (1) BE601304A (fr)
BR (1) BR6127708D0 (fr)
FR (1) FR1235M (fr)
GB (1) GB963264A (fr)
NL (1) NL262354A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL289785A (fr) * 1962-11-29
US3274057A (en) * 1963-10-30 1966-09-20 Merck & Co Inc Stable hexylresorcinol compositions
IT1212896B (it) * 1983-11-08 1989-11-30 Della Valle Francesco Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4940728A (en) * 1985-05-17 1990-07-10 Postley John E Treatment for sino-nasal congestion
DE68915203T2 (de) * 1988-03-22 1994-09-22 Fisons Plc, Ipswich, Suffolk Pharmazeutische Mischungen.
CA2252617A1 (fr) * 1996-05-01 1997-11-06 Imarx Pharmaceutical Corp. Procedes d'apport de composes dans une cellule

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2350435A (en) * 1942-05-11 1944-06-06 Claude R Wickard Derivatives of ascorbic acid
BE555319A (fr) * 1956-03-21 1900-01-01

Also Published As

Publication number Publication date
BR6127708D0 (pt) 1973-07-03
BE601304A (fr) 1961-09-14
US3039929A (en) 1962-06-19
FR1235M (fr) 1962-04-09
GB963264A (en) 1964-07-08

Similar Documents

Publication Publication Date Title
AT229108B (fr)
BE620016A (fr)
BE588555A (fr)
BE598272A (fr)
BE599277A (fr)
BE601582A (fr)
BE602391A (fr)
BE603032A (fr)
BE603337A (fr)
BE603543A (fr)
BE603645A (fr)
BE622764A (fr)
BE604225A (fr)
BE604516A (fr)
BE604732A (fr)
BE604778A (fr)
BE604885A (fr)
BE604940A (fr)
BE605319A (fr)
BE605708A (fr)
BE606009A (fr)
BE606040A (fr)
BE606111A (fr)
BE606275A (fr)
BE606303A (fr)